Lupin wins USFDA okay for HIV-1 drug Raltegravir Ruchika Sharma9 May 2025 4:45 AMMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (USFDA) has approved the Company's...
Gilead new drug applications for twice-yearly Lenacapavir for HIV Prevention accepted by USFDA under priority review Ruchika Sharma19 Feb 2025 8:00 AMFoster City: Gilead Sciences, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application...
USFDA approves Lupin drug for HIV-1 infection Ruchika Sharma18 Dec 2024 11:41 AMMumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA)...
Lupin bags tentative USFDA nod for Raltegravir Tablets for HIV-1 infection Ruchika Sharma9 Nov 2024 5:30 AMMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Johnson and Johnson gets European Commission nod for expanded use of HIV 1 therapy Edurant in younger pediatric patients Ruchika Sharma1 Nov 2024 5:30 AMBeerse: Johnson & Johnson has announced that the European Commission (EC) has approved EDURANT (rilpivirine) for the treatment of HIV-1 infection...
USFDA nod to Johnson and Johnson EDURANT PED for certain pediatric patients living with HIV-1 Ruchika Sharma20 March 2024 7:00 AMTitusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved EDURANT PED (rilpivirine) for the...
Aurobindo Pharma bags USFDA nod for HIV drug Darunavir Ruchika Sharma29 Nov 2023 9:16 AMHyderabad: Aurobindo Pharma Limited has announced that the Company has received final approval from the US Food & Drug Administration (USFDA) to...
HIV-1 injectable treatment: GSK's ViiV Healthcare gets Chinese nod for Vocabria used in combination with Rekambys Ruchika Sharma26 Oct 2023 10:51 AMLondon: GSK plc has announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as...
Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy: NEJM Dr. Kamal Kant Kohli4 Sept 2022 2:00 PMDolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the...
Molbio Diagnostics unveils Truenat RT-PCR test for HIV Ruchika Sharma18 Aug 2022 6:36 AMCompany's Chief Technical Officer Chandrasekhar Nair said, "We needed an effective means of testing at point-of-care, which is cost-effective and has...
Gilead Sciences Lenacapavir MAA gets EMA validation to treat HIV-1 Ruchika Sharma22 Aug 2021 4:30 AMFoster City: Gilead Sciences, Inc. has recently announced that the company's Marketing Authorization Application (MAA) for lenacapavir, an...
